My Market Wizard

GSK plc 6-K Analysis & Summary – 2/21/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

GSK plc

Filing date:

02/21/2025

TLDR:

GSK plc granted conditional share awards to its Persons Discharging Managerial Responsibilities under the GlaxoSmithKline 2017 Performance Share Plan.

ELI5:

GSK gave its top managers a chance to earn company shares if they meet certain performance goals over the next three years.

Accession #:

0001654954-25-001748

Published on

Analyst Summary

  • GSK plc granted conditional share awards to PDMRs and PCAs on February 17, 2025.
  • The awards were granted under the GlaxoSmithKline 2017 Performance Share Plan.
  • Vesting of the awards is contingent on achieving performance targets over a three-year period from January 1, 2025, to December 31, 2027.
  • The performance measures will be disclosed in a separate release and the Company’s 2024 Annual Report.
  • Executive Directors’ awards are subject to an additional two-year holding period.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️